rs794727846

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PS3PM1PM2PM4PP3PP5

The NM_000546.6(TP53):​c.704_709delACTACA​(p.Asn235_Tyr236del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV004933131: Functional studies indicate this variant impacts protein function [PMID:29979965]." and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. N235N) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 30)

Consequence

TP53
NM_000546.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:3

Conservation

PhyloP100: 9.31

Publications

2 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV004933131: Functional studies indicate this variant impacts protein function [PMID: 29979965].; SCV002662038: Based on the majority of available evidence to date, this variant is likely to be pathogenic. Cho Y et al., Science 1994 Jul; 265(5170):346-55).
PM1
In a hotspot region, there are 49 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 32 uncertain in NM_000546.6
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_000546.6.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
Variant 17-7674253-ATGTAGT-A is Pathogenic according to our data. Variant chr17-7674253-ATGTAGT-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 198431.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
NM_000546.6
MANE Select
c.704_709delACTACAp.Asn235_Tyr236del
disruptive_inframe_deletion
Exon 7 of 11NP_000537.3
TP53
NM_001126112.3
c.704_709delACTACAp.Asn235_Tyr236del
disruptive_inframe_deletion
Exon 7 of 11NP_001119584.1K7PPA8
TP53
NM_001407262.1
c.704_709delACTACAp.Asn235_Tyr236del
disruptive_inframe_deletion
Exon 8 of 12NP_001394191.1K7PPA8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000269305.9
TSL:1 MANE Select
c.704_709delACTACAp.Asn235_Tyr236del
disruptive_inframe_deletion
Exon 7 of 11ENSP00000269305.4P04637-1
TP53
ENST00000445888.6
TSL:1
c.704_709delACTACAp.Asn235_Tyr236del
disruptive_inframe_deletion
Exon 7 of 11ENSP00000391478.2P04637-1
TP53
ENST00000610292.4
TSL:1
c.587_592delACTACAp.Asn196_Tyr197del
disruptive_inframe_deletion
Exon 6 of 10ENSP00000478219.1P04637-4

Frequencies

GnomAD3 genomes
Cov.:
30
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
30

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
1
-
Hereditary cancer-predisposing syndrome (2)
1
1
-
Li-Fraumeni syndrome 1 (2)
1
-
-
Li-Fraumeni syndrome (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
9.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs794727846; hg19: chr17-7577571; COSMIC: COSV52740030; COSMIC: COSV52740030; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.